Modulators of cellular adhesion

Details Modulators of cellular adhesion Modulators of cellular adhesion

2008-01-01

2008-01-01

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S307000

Reexamination Certificate

active

07314938

ABSTRACT:
The present invention provides compounds having formula (I):and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).

REFERENCES:
patent: 5149780 (1992-09-01), Plow et al.
patent: 5288854 (1994-02-01), Diamond et al.
patent: 5298492 (1994-03-01), Neustadt et al.
patent: 5340800 (1994-08-01), Liu et al.
patent: 5397791 (1995-03-01), Hartman et al.
patent: 5424399 (1995-06-01), Arnaout
patent: 5470953 (1995-11-01), Gallatin et al.
patent: 5585359 (1996-12-01), Breslin et al.
patent: 5973188 (1999-10-01), Alig et al.
patent: 6204280 (2001-03-01), Gante et al.
patent: 6294522 (2001-09-01), Zablocki et al.
patent: 6340679 (2002-01-01), Peyman et al.
patent: 6358976 (2002-03-01), Wityak et al.
patent: 6605597 (2003-08-01), Zablocki et al.
patent: 6653478 (2003-11-01), Urbanski et al.
patent: 6803384 (2004-10-01), Fotouhi et al.
patent: 2002/0115692 (2002-08-01), Archibald et al.
patent: 2002/0132807 (2002-09-01), Wang et al.
patent: 2002/0177591 (2002-11-01), O'Donnell et al.
patent: 2003/0166630 (2003-09-01), Auvin et al.
patent: 2004/0122047 (2004-06-01), Fenton et al.
patent: 314863 (1989-05-01), None
patent: 362526 (1990-04-01), None
patent: 362531 (1990-04-01), None
patent: 4193895 (1992-07-01), None
patent: WO 90/03400 (1990-04-01), None
patent: WO 90/10652 (1990-09-01), None
patent: WO 90/13316 (1990-11-01), None
patent: WO 91/19511 (1991-12-01), None
patent: WO 92/03473 (1992-03-01), None
patent: WO 94/03481 (1994-02-01), None
patent: WO 94/11400 (1994-05-01), None
patent: WO 95/04531 (1995-02-01), None
patent: WO 95/28170 (1995-10-01), None
patent: WO 96/09836 (1996-04-01), None
patent: WO 98/46599 (1998-10-01), None
patent: WO 99/49856 (1999-10-01), None
patent: WO 00/21920 (2000-04-01), None
patent: WO 00/44731 (2000-08-01), None
patent: WO 01/27102 (2001-04-01), None
patent: WO 01/87840 (2001-11-01), None
patent: WO 02/50080 (2002-06-01), None
patent: WO 02/59114 (2002-08-01), None
patent: WO 2005/014532 (2005-02-01), None
patent: WO 2005/014533 (2005-02-01), None
patent: WO 2005/044817 (2005-05-01), None
Boschelli, D. H.; et al., “3-Alkoxybenzo[b]thiophene-2-carboxamides as Inhibitors of Neutrophil-Endothelial Cell Adhesion”,J. Med. Chem., 1994, 37(6): 717-718.
Boschelli, D. H.; et al., “Inhibition of E-Selectin-, ICAM-1-, and VCAM-1-Mediated Cell Adhesion by Benzo[b]thiophene-, Benzufuran-, Indole-, and Naphthalene-2-carboxamides: Identification of PD 144795 as an Antiinflammatory Agent”,J. Med. Chem., 1995, 38: 4597-4614.
Chang, Y. H.; et al., “Effects of pharmacologic agents on the reversed passive Arthus reaction in the rat”Eur. J. Pharmacol, 1981, 69(2):155-164.
Cosimi, A. B.; et al., “In Vivo Effects of Monoclonal Antibody to ICAM-1 (CD54) in Nonhuman Primates with Renal Allografts1,”J. Immunol., 1990, 144(12): 4604-4612.
Diamond, M., et al., “The dynamic regulation of integrin adhesiveness”,Current Biology, 1994, 4(6): 506-532.
Fischer, A.; et al., “Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation”,The Lancet, 1986, 2: 1058-1060.
Gorski, A.; “The role of cell adhesion molecules in immunopathology”,Immunology Today, 1994, 15: 251-255.
Hildreth, J., et al., “Monoclonal Antibodies Against Porcine LFA-1: Species Cross-Reactivity and Functional Effects of β-Subunit-Specific Antibodies”, Molecular Immunology, 1989, 26(9): 883-895.
Kavanaugh, A.; et al., “Treatment of Refractory Rheumatoid Arthritis with a Monoclonal Antibody to Intercellular Adhesion Molecule 1”,Arthritis Rheum., 1994, 37(7): 992-1004.
Kishimoto, T. K., et al., “Integrins, ICAMs, and Selectins: Role and Regulation of Adhesion Molecules in Neutrophil Recruitment to Inflammatory Sites”,Adv. Pharmacol., 1994, 25: 117-169.
Le Mauff, B.; et al., “Effect of Anti-LFA1 (CD11a) Monoclonal Antibodies in Acute Rejection in Human Kidney Transplantation”,Transplantation, 1991, 52(2): 291-295.
Musza, L. L.; et al., “Potent New Cell Adhesion Inhibitory Compounds from the Root ofTrichilia rubra”, Tetrahedron, 1994, 50(39): 11369-11378.
Plobeck et al., “New Diarylmethylpiperazines as Potent and Selective Nonpeptidic δ Opioid Receptor Agonists with Increased in Vitro Metabolic Stability”,J.Med.Chem., 2000, 43:3878-3894.
Rothlein, R., et al., “1. Leukocyte Adhesion in Inflammation: From Discovery to the Clinic”,Adhesion Molecules; Wegner, C. D., Ed.; 1994, 1-8.
Sanfilippo, P. J.; et al. “Novel Thiazole Based Heterocycles as Inhibitors of LFA-1/ICAM-1 Mediated Cell Adhesion”,J. Med. Chem., 1995, 38: 1057-1059.
Springer, T., “Adhesion Receptors of the immune system”,Nature, 1990, 346: 425-434.
International Search Report from corresponding International Application No.: PCT/US2004/036942.

Affiliated with

Also associated with

Rating

Modulators of cellular adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of cellular adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of cellular adhesion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2793608